|
Good manufacturing practice
(GMP) is that part of quality assurance which ensures that products are
consistently produced and controlled to the quality standards appropriate to
their intended use and as required by the marketing authorization. GMP is
aimed primarily at diminishing the risks inherent in any pharmaceutical
production, which may broadly be categorized in two groups: cross
contamination/mix-ups and false labelling. Above all, manufacturers must not
place patients at risk due to inadequate safety, quality or efficacy; for
this reason, risk assessment has come to play an important role in WHO quality
assurance guidelines.
Kindly click for information about WHO GMP guidelines: http://www.who.int/medicines/areas/quality_safety/quality_assurance/production/en/index.html
 Quality Assurance
of Pharmaceuticals
A Compendium of WHO GMP text
and guidelines in the area of inspection and risk analysis
|
